StockBasis
LIVE · 2026-10-31 05:20 UTC

AMGN Amgen Inc

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official

Market Value*
$150.10B
Revenue (FY)
$36.75B 2025-12-31
Net Income (FY)
$7.71B
P/E (float-based)
19.5

American multinational biopharmaceutical company.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 318154 · SEC filings · revenue ranking · home